Furthermore, while the neural classification has been removed, further advances in glioma genetic characterization have allowed updating GBM classification as isocitrate dehydrogenase (IDH)-wild type or IDH-mutant, which roughly correspond to primary and secondary GBM, respectively [52]. This evidence concerns the gene IDH1 and glioblastoma.